Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 12:39:16 UTC |
---|
Update Date | 2021-09-26 23:07:15 UTC |
---|
HMDB ID | HMDB0253796 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 3-{1-[6,7-Diethoxy-2-(morpholin-4-yl)quinazolin-4-yl]piperidin-4-yl}-1,6-dimethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione |
---|
Description | 3-{1-[6,7-Diethoxy-2-(morpholin-4-yl)quinazolin-4-yl]piperidin-4-yl}-1,6-dimethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups. Based on a literature review very few articles have been published on 3-{1-[6,7-Diethoxy-2-(morpholin-4-yl)quinazolin-4-yl]piperidin-4-yl}-1,6-dimethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione. This compound has been identified in human blood as reported by (PMID: 31557052 ). 3-{1-[6,7-diethoxy-2-(morpholin-4-yl)quinazolin-4-yl]piperidin-4-yl}-1,6-dimethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 3-{1-[6,7-Diethoxy-2-(morpholin-4-yl)quinazolin-4-yl]piperidin-4-yl}-1,6-dimethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCOC1=C(OCC)C=C2C(=C1)N=C(N=C2N1CCC(CC1)N1C(=O)N(C)C2=C(C=C(C)C=C2)C1=O)N1CCOCC1 InChI=1S/C31H38N6O5/c1-5-41-26-18-22-24(19-27(26)42-6-2)32-30(36-13-15-40-16-14-36)33-28(22)35-11-9-21(10-12-35)37-29(38)23-17-20(3)7-8-25(23)34(4)31(37)39/h7-8,17-19,21H,5-6,9-16H2,1-4H3 |
---|
Synonyms | Value | Source |
---|
3-(1-(6,7-Diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl)-1,6-dimethyl-2,4-(1H,3H)-quinazolinedione | MeSH |
|
---|
Chemical Formula | C31H38N6O5 |
---|
Average Molecular Weight | 574.682 |
---|
Monoisotopic Molecular Weight | 574.290368348 |
---|
IUPAC Name | 3-{1-[6,7-diethoxy-2-(morpholin-4-yl)quinazolin-4-yl]piperidin-4-yl}-1,6-dimethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione |
---|
Traditional Name | 3-{1-[6,7-diethoxy-2-(morpholin-4-yl)quinazolin-4-yl]piperidin-4-yl}-1,6-dimethylquinazoline-2,4-dione |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCOC1=C(OCC)C=C2C(=C1)N=C(N=C2N1CCC(CC1)N1C(=O)N(C)C2=C(C=C(C)C=C2)C1=O)N1CCOCC1 |
---|
InChI Identifier | InChI=1S/C31H38N6O5/c1-5-41-26-18-22-24(19-27(26)42-6-2)32-30(36-13-15-40-16-14-36)33-28(22)35-11-9-21(10-12-35)37-29(38)23-17-20(3)7-8-25(23)34(4)31(37)39/h7-8,17-19,21H,5-6,9-16H2,1-4H3 |
---|
InChI Key | MXOWYPVUVPQDNZ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazanaphthalenes |
---|
Sub Class | Benzodiazines |
---|
Direct Parent | Quinazolinamines |
---|
Alternative Parents | |
---|
Substituents | - Quinazolinamine
- Phenol ether
- Dialkylarylamine
- Alkyl aryl ether
- Aminopyrimidine
- Pyrimidone
- Morpholine
- Oxazinane
- Piperidine
- Pyrimidine
- Benzenoid
- Imidolactam
- Heteroaromatic compound
- Vinylogous amide
- Lactam
- Urea
- Dialkyl ether
- Ether
- Oxacycle
- Azacycle
- Hydrocarbon derivative
- Organic oxygen compound
- Organic oxide
- Amine
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 225.658 | 30932474 | DeepCCS | [M-H]- | 223.623 | 30932474 | DeepCCS | [M-2H]- | 256.862 | 30932474 | DeepCCS | [M+Na]+ | 231.571 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedMetabolite | SMILES | Kovats RI Value | Column Type | Reference |
---|
3-{1-[6,7-Diethoxy-2-(morpholin-4-yl)quinazolin-4-yl]piperidin-4-yl}-1,6-dimethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione | CCOC1=C(OCC)C=C2C(=C1)N=C(N=C2N1CCC(CC1)N1C(=O)N(C)C2=C(C=C(C)C=C2)C1=O)N1CCOCC1 | 4637.9 | Standard polar | 33892256 | 3-{1-[6,7-Diethoxy-2-(morpholin-4-yl)quinazolin-4-yl]piperidin-4-yl}-1,6-dimethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione | CCOC1=C(OCC)C=C2C(=C1)N=C(N=C2N1CCC(CC1)N1C(=O)N(C)C2=C(C=C(C)C=C2)C1=O)N1CCOCC1 | 4489.3 | Standard non polar | 33892256 | 3-{1-[6,7-Diethoxy-2-(morpholin-4-yl)quinazolin-4-yl]piperidin-4-yl}-1,6-dimethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione | CCOC1=C(OCC)C=C2C(=C1)N=C(N=C2N1CCC(CC1)N1C(=O)N(C)C2=C(C=C(C)C=C2)C1=O)N1CCOCC1 | 5257.4 | Semi standard non polar | 33892256 |
|
---|